Nabriva Therapeutics plc (49) | Human Resources (20)
Browse by Subcategory
Recent Contracts
-
Form of Contingent RSU Award Agreement under the 2020 Share Incentive Plan, as amended
(Filed With SEC on March 29, 2022)
-
Employment Agreement dated August 23, 2021 by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia
(Filed With SEC on November 9, 2021)
-
Consulting Agreement, dated May 3, 2021, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz
(Filed With SEC on May 6, 2021)
-
Retention Agreement, dated August 5, 2020, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz
(Filed With SEC on November 5, 2020)
-
Employment Agreement dated August 24, 2021 by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger
(Filed With SEC on November 9, 2021)
-
2021 Inducement Share Incentive Plan, as amended
(Filed With SEC on October 8, 2021)
-
Form of Share Option Agreement under the 2021 Inducement Share Incentive Plan
(Filed With SEC on May 6, 2021)
-
Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Automatic Sale)
(Filed With SEC on May 6, 2021)
-
Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Share Withholding)
(Filed With SEC on May 6, 2021)
-
Form of Share Option Agreement under the 2020 Share Incentive Plan, as amended
(Filed With SEC on May 6, 2021)
-
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Sender Consulting LLC, dated as of March 9, 2021
(Filed With SEC on March 11, 2021)
-
Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan, dated as of March 10, 2021
(Filed With SEC on March 11, 2021)
-
2021 Inducement Share Incentive Plan
(Filed With SEC on March 11, 2021)
-
Third Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of March 10, 2021
(Filed With SEC on March 11, 2021)
-
Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of March 10, 2021
(Filed With SEC on March 11, 2021)
-
Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Robert Crotty, dated as of March 10, 2021
(Filed With SEC on March 11, 2021)
-
Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan (Share Withholding)
(Filed With SEC on March 12, 2020)
-
Form of Share Option / Cash Settled Share Appreciation Right Agreement under the 2020 Share Incentive Plan
(Filed With SEC on March 12, 2020)
-
2020 Share Incentive Plan
(Filed With SEC on March 12, 2020)
-
Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz, dated as of March 21, 2018
(Filed With SEC on March 12, 2019)